|
If In Ovo EGF Supplementation Has These Limitations, Does It Still Hold Any Value?
Consider it from another angle: if this paper had ultimately proven that "EGF works extremely well," all we would have gained is a new product direction. But because it didn't produce the ideal outcome, it has instead left us with far more questions worth thinking through — Why did the receptor respond, yet production performance failed to improve? Why do different species produce different outcomes? Why might a single supplementation be insufficient to complete the entire regulatory process? These questions are worth far more to the industry's continued exploration than a simple "it works" or "it doesn't." ![]() How Many Questions Must a Functional Substance Actually Answer?
HUADE Technical Perspective The original purpose of Huade Thursday has never been simply to introduce a research paper. What we hope to do, instead, is translate scientific findings into language the industry can understand, reflect on, and apply. Every paper is only a starting point — what truly matters is identifying the underlying questions within it, understanding the principles at work, and ultimately transforming those insights into solutions that drive the industry forward. These four articles — from the critical window of early-life development, to the recognition of the EGF signal, to the analysis of why a confirmed mechanism failed to translate into production performance — are, at their core, all telling the same story: what truly drives industry progress is not a single experimental result, but a scientific attitude that keeps asking "why." And it is precisely this attitude that builds a genuine bridge between basic research and industrial practice. |
HUADE INSIGHTS | From Birth to Health: Where Is Animal Health Management Headed?
HUADE VOICE | 11.18–11.24 | World AMR Awareness Week
HUADE INSIGHTS | Why Can the Same Functional Factor Work So Differently in Different Animals?
HUADE VOICE | Winter Livestock Care: Get These Four Things Right First